These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A. Guardiani E, Sadoughi B, Blitzer A, Sirois D. Laryngoscope; 2014 Feb; 124(2):413-7. PubMed ID: 23818108 [Abstract] [Full Text] [Related]
5. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial. Burmeister J, Holle D, Bock E, Ose C, Diener HC, Obermann M. Trials; 2015 Dec 03; 16():550. PubMed ID: 26634453 [Abstract] [Full Text] [Related]
6. Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain. Ngeow WC, Nair R. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar 03; 109(3):e47-50. PubMed ID: 20219585 [Abstract] [Full Text] [Related]
7. Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia. Crespi J, Bratbak D, Dodick DW, Matharu M, Jamtøy KA, Tronvik E. Headache; 2019 Sep 03; 59(8):1229-1239. PubMed ID: 31342515 [Abstract] [Full Text] [Related]
8. Intra-articular Botulinum Toxin Type A: a new approach to treat arthritis joint pain. Mahowald ML, Krug HE, Singh JA, Dykstra D. Toxicon; 2009 Oct 03; 54(5):658-67. PubMed ID: 19351542 [Abstract] [Full Text] [Related]
9. Botulinum toxin type A as an alternative way to treat trigeminal neuralgia: a systematic review. Ostrowski H, Roszak J, Komisarek O. Neurol Neurochir Pol; 2019 Oct 03; 53(5):327-334. PubMed ID: 31397877 [Abstract] [Full Text] [Related]